In last trading session, Cocrystal Pharma, Inc. (NASDAQ:COCP) saw 1,694,671 shares changing hands with its beta currently measuring -0.19. Company’s recent per share price level of $1 trading at $0.05 or 5.23% at ring of the bell on the day assigns it a market valuation of $73.97 Million. That closing price of COCP’s stock is at a discount of -204% from its 52-week high price of $3.04 and is indicating a premium of 61% from its 52-week low price of $0.39. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.06 Million shares which gives us an average trading volume of 4.24 Million if we extend that period to 3-months.

For Cocrystal Pharma, Inc. (COCP), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 2. Splitting up the data highlights that, out of 2 analysts covering the stock, none rated the stock as a Sell while none recommended an Overweight rating for the stock. None suggested the stock as a Hold whereas 2 see the stock as a Buy. None analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -$0.05 in the current quarter.

Cocrystal Pharma, Inc. (NASDAQ:COCP) trade information

Upright in the green today for gaining 5.23%, in the last five days COCP remained trading in the green while hitting it’s week-highest on Wednesday, Sep 16 when the stock touched $1.02 price level, adding 1.99% to its value on the day. Cocrystal Pharma, Inc.’s shares saw a change of 101.76% in year-to-date performance and have moved 3.06% in past 5-day. Cocrystal Pharma, Inc. (NASDAQ:COCP) showed a performance of -47.93% in past 30-days. Number of shares sold short was 251.51 Million shares which calculate 59.32 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of $5 to the stock, which implies a rise of 400% to its current value. Analysts have been projecting $5 as a low price target for the stock while placing it at a high target of $5. It follows that stock’s current price would jump +400% in reaching the projected high whereas dropping to the targeted low would mean a loss of 400% for stock’s current value.

Cocrystal Pharma, Inc. (COCP) estimates and forecasts

1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $450Million for the same. And 1 analysts are in estimates of company making revenue of $450Million in the next quarter that will end in December 01, 2020.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 0% during past 5 years. In 2020, company’s earnings growth rate is likely to be around 13.7% while estimates for its earnings growth in next 5 years are of 0%